These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26623947)

  • 21. G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity.
    Goldberg DS; Vijayalakshmi N; Swaan PW; Ghandehari H
    J Control Release; 2011 Mar; 150(3):318-25. PubMed ID: 21115079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor potential of a novel camptothecin derivative, ZBH-ZM-06.
    Wu D; Zhao DW; Li YQ; Shi WG; Yin QL; Tu ZK; Yu YY; Zhong BH; Yu H; Bao WG
    Oncol Rep; 2018 Feb; 39(2):871-879. PubMed ID: 29251321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
    Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
    Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel disulfide bond bridged 7-ethyl-10-hydroxyl camptothecin-undecanoic acid conjugate/human serum albumin nanoparticles for breast cancer therapy.
    Zhang Y; Wang J; Liu C; Xing H; Jiang Y; Li X
    J Mater Chem B; 2023 Mar; 11(11):2478-2489. PubMed ID: 36843543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DTS-108, a novel peptidic prodrug of SN38: in vivo efficacy and toxicokinetic studies.
    Meyer-Losic F; Nicolazzi C; Quinonero J; Ribes F; Michel M; Dubois V; de Coupade C; Boukaissi M; Chéné AS; Tranchant I; Arranz V; Zoubaa I; Fruchart JS; Ravel D; Kearsey J
    Clin Cancer Res; 2008 Apr; 14(7):2145-53. PubMed ID: 18381956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a targeted prodrug strategy of enhance oral absorption of poorly water-soluble compounds.
    Chan OH; Schmid HL; Stilgenbauer LA; Howson W; Horwell DC; Stewart BH
    Pharm Res; 1998 Jul; 15(7):1012-8. PubMed ID: 9688053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of surfactants to enhance the solubility and stability of the water-insoluble anticancer drug SN38 into liquid crystalline phase nanoparticles.
    Ranneh AH; Iwao Y; Noguchi S; Oka T; Itai S
    Int J Pharm; 2016 Dec; 515(1-2):501-505. PubMed ID: 27793711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.
    Vooturi SK; Kadam RS; Kompella UB
    Mol Pharm; 2012 Nov; 9(11):3136-46. PubMed ID: 23003105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
    Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F
    Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, characterization, and antitumor evaluation of the albumin-SN38 conjugate.
    Yao Y; Su X; Xie Y; Wang Y; Kang T; Gou L; Yi C; Yang J
    Anticancer Drugs; 2013 Mar; 24(3):270-7. PubMed ID: 23233044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy.
    Bi Y; Lee RJ; Wang X; Sun Y; Wang M; Li L; Li C; Xie J; Teng L
    Int J Nanomedicine; 2018; 13():5811-5822. PubMed ID: 30323583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach.
    Gupta SV; Gupta D; Sun J; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2011 Dec; 8(6):2358-67. PubMed ID: 21905667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
    Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
    J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro evaluation of dendrimer prodrugs for oral drug delivery.
    Najlah M; Freeman S; Attwood D; D'Emanuele A
    Int J Pharm; 2007 May; 336(1):183-90. PubMed ID: 17188439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastoma.
    Iyer R; Croucher JL; Chorny M; Mangino JL; Alferiev IS; Levy RJ; Kolla V; Brodeur GM
    Cancer Lett; 2015 May; 360(2):205-12. PubMed ID: 25684664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancreatic Cancer Therapy.
    Zhong ZX; Li XZ; Liu JT; Qin N; Duan HQ; Duan XC
    Int J Nanomedicine; 2023; 18():1281-1298. PubMed ID: 36945256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral delivery of nanoparticles containing anticancer SN38 and hSET1 antisense for dual therapy of colon cancer.
    Dinarvand M; Kiani M; Mirzazadeh F; Esmaeili A; Mirzaie Z; Soleimani M; Dinarvand R; Atyabi F
    Int J Biol Macromol; 2015; 78():112-21. PubMed ID: 25858880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological activities of a pH-dependently activated water-soluble prodrug of a novel hexacyclic camptothecin analog.
    Ohwada J; Ozawa S; Kohchi M; Fukuda H; Murasaki C; Suda H; Murata T; Niizuma S; Tsukazaki M; Ori K; Yoshinari K; Itezono Y; Endo M; Ura M; Tanimura H; Miyazaki Y; Kawashima A; Nagao S; Namba E; Ogawa K; Kobayashi K; Okabe H; Umeda I; Shimma N
    Bioorg Med Chem Lett; 2009 May; 19(10):2772-6. PubMed ID: 19362835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SN38-based albumin-binding prodrug for efficient targeted cancer chemotherapy.
    Huang Y; Wang L; Cheng Z; Yang B; Yu J; Chen Y; Lu W
    J Control Release; 2021 Nov; 339():297-306. PubMed ID: 34619226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin.
    Lu J; Liu C; Wang P; Ghazwani M; Xu J; Huang Y; Ma X; Zhang P; Li S
    Biomaterials; 2015 Sep; 62():176-87. PubMed ID: 26057133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.